Abstract:Longevity, in the context of healthy aging, is the ultimate goal of health care. It also represents the rationale for some of the most significant endpoints in research. Aging is commonly associated with frailty. However, it is questionable whether the concept of so-called normal regarding frailty exists, which is the threshold for pathology. A strategy is needed to integrate assessment and management of frailty, with the dual aim of both increasing life expectancy and quality of life. A good insight into metabolism is fundamental to the understanding of pathophysiologic processes. Imaging of metabolism runs the gamut from advanced nuclear medicine and magnetic resonance imaging (MRI) techniques targeted to assess specific metabolic imaging biomarkers to the clinical diagnosis of a wide spectrum of metabolic bone diseases (MBDs). Theoretically, all diseases have a metabolic anima to understand, defined not only by physiology but also the need to be considered in the context of biomechanics and genetics. This is very apparent for metabolic diseases with effects on the musculoskeletal (MSK) system. Muscles, bones, and fat deposits are the components that make up most of our body weight. The MSK system is central to understand, prevent, and manage metabolic conditions and frailty. The role of clinical radiologists is crucial for the benefit of the community, from screening to monitoring the effects of treatments. The ultimate problem of MBDs is represented by fractures and the consequences of frailty. For instance, the effects of osteoporosis and sarcopenia have an unparalleled impact on health care systems, in addition to severely impacting a patient's quality of life. Despite metabolic changes that occur at a molecular level, understanding MBDs relies increasingly on imaging. This is true in both research and clinical practice. Imaging is capable of assessing (and sometimes discovering) different in vivo biomarkers of metabolism and frailty, aside from detecting fractures (that also sometimes poses a challenge). Imaging is now making visible what was invisible or impossible to assess only a few years ago, with new techniques and tools in clinical practice. This issue of Seminars explores the added value of imaging in the diagnosis and management of MBDs, with the invaluable contributions of several internationally acclaimed and credited authors. Twelve articles describe updates on both older and newer techniques in the radiologic management of MBDs, such as dual-energy X-ray absorptiometry (DXA), Trabecular Bone Score (TBS), radiofrequency echographic multi spectrometry (REMS), quantitative computed tomography (QCT), high-resolution peripheral quantitative computed tomography (HRpQCT), and MR imaging, after introducing insights into the latest research on bone marrow. Specific focused articles address hot topics such as body composition, artificial intelligence, opportunistic screening, vertebral fractures, and interventional radiology. As per tradition, the History Page reminds us of the beauty of our discipline. We hope you will enjoy this issue and that it helps you translate science into practice in the field of MBD diagnosis and management, in the light of the research on the most recent imaging. Article published online: 15 October 2024 © 2024. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

Radiofrequency Echographic Multi-Spectrometry in the Diagnosis of Metabolic Bone Disease

Radiofrequency Echographic Multi Spectrometry (R.E.M.S.): New Frontiers for Ultrasound Use in the Assessment of Bone Status—A Current Picture

Radiofrequency Multi Echographic Spectrometry (REMS) Technology in Patients With Bone Artifacts

Radiofrequency echographic multi spectrometry (REMS) in the diagnosis and management of osteoporosis: state of the art

The Advantages of Radiofrequency Echographic MultiSpectrometry in the Evaluation of Bone Mineral Density in a Population with Osteoarthritis at the Lumbar Spine

Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength: state of the art—outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

Imaging of Metabolic Bone Diseases

Radiofrequency echographic multi-spectrometry and DXA for the evaluation of bone mineral density in a peritoneal dialysis setting

Radiofrequency echographic multi-spectrometry-based measurement of bone mineral density in patients with severe motor and intellectual disability: An opportunity for patients with severe scoliosis and hip dislocation

Radiographic Predictors for Bone Mineral Loss CORTICAL THICKNESS AND INDEX OF THE DISTAL FEMUR

DXA: New Concepts and Tools Beyond Bone Mineral Density

Magnetic Resonance Assessment of Bone Quality in Metabolic Bone Diseases

Bone health status evaluation in men by means of REMS technology

Physical Performance of Geriatric Women and Its Impact on Fracture Risk and Bone Mineral Density Assessed with Radiofrequency Echographic Multispectrometry (REMS)

Correlation between serum vitamin D levels and bone mass density evaluated by radiofrequency echographic multi-spectrometry technology (REMS) in menopausal women

Metabolic Bone Diseases: Recommendations for Interventional Radiology

New perspectives in echographic diagnosis of osteoporosis on hip and spine

A multi-imaging modality study of bone density, bone structure and the muscle - bone unit in end-stage renal disease.

Imaging methods for bone mass evaluation during childhood and adolescence: an update

Evaluation of MR Spectroscopy and Diffusion-Weighted MRI in Detecting Bone Marrow Changes in Postmenopausal Women with Osteoporosis.

Functional Photoacoustic and Ultrasonic Assessment of Osteoporosis: A Clinical Feasibility Study